Valle William

SEC Form 4 insider trading activity

Valle William has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 15, 2026.

On the most recent filing, Valle William is listed as Director at TriSalus Life Sciences, Inc. Inside the rolling window, Valle William reported 1 open-market purchase totaling $125K in TLSI and no open-market sales.

Companies traded

Other insiders at TLSI

Insider Buying

$125K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TLSI
Valle William
Purchase$125KFeb 23SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Valle William made?

Valle William has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.

Which companies does Valle William trade?

Valle William has filed SEC Form 4 disclosures for 1 company, including TLSI.

When was Valle William's most recent SEC Form 4 filing?

Valle William's most recent SEC Form 4 filing on Tracefour is dated May 15, 2026.

What is Valle William's total buy and sell value in the current window?

Inside the rolling retention window, Valle William bought $125K and sold $0 based on SEC Form 4 filings.

What was Valle William's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 30,487 TLSI shares on 2026-02-23, worth $125K, per SEC Form 4 filings.